News

Via has shown improving financial metrics while maintaining growth. Its net loss margin improved from (47)% in 2023 to (27)% in 2024, while Adjusted EBITDA margin improved from (37)% to (16)% during ...
Investing.com -- Trading was halted in Tonix Pharmaceuticals (NASDAQ:TNXP) stock Friday ahead of a major announcement that the U.S. Food and Drug Administration (FDA) has approved Tonmya for the ...
Investing.com -- U.S. President Donald Trump and Russian President Vladimir Putin have started their talks in Anchorage, Alaska on Friday. The two world leaders were seen sitting side by side but made ...
Investors should continually evaluate buyback programs in the context of insider activity. A buyback combined with insider ...
Investing.com -- U.S.-India focused clinical-stage pharmaceutical maker Vyome Holdings (Nasdaq: HIND) rang the opening bell ...
Investing.com -- President Donald Trump’s "Make America Healthy Again" commission will not recommend new restrictions on farm pesticide use in its upcoming report on children’s health, according to a ...
Investing.com -- A Russian government plane landed in Alaska ahead of scheduled talks between the Russian and U.S. presidents on Friday, according to flight tracking system Flightradar24. The aircraft ...
Investing.com -- U.S. Health and Human Services Secretary Robert F. Kennedy Jr. firmly denied rumors about a potential 2028 presidential run on Friday. Kennedy took to social media platform X to ...
Speaking to reporters aboard Air Force One on Friday, Trump stated he had no predetermined metrics for what would constitute a successful meeting with the Russian leader. "I can't tell you that. I don ...
Investing.com -- Cleveland-Cliffs Inc (NYSE:CLF) stock gained 2% Friday afternoon following a Bloomberg report that the company has secured multiyear fixed-price contracts with multiple U.S.
Investing.com -- Lyft (NASDAQ:LYFT) stock rose 9% Friday, marking its biggest gain since May, following the announcement that ...
Investing.com -- JPMorgan sold approximately 5 to 6 million CoreWeave shares in a block trade at around $97 per share, according to CNBC, which cited unnamed sources. Goldman Sachs and Morgan Stanley ...